Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 49 positions · Total reported value $1.73B · Top-10 concentration 58.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Cormorant Asset Management, LP disclosed 49 equity positions with a combined reported value of $1.73B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were MLTX ($373.49M), CRBP ($91.63M), ACLX ($84.16M). By sector, the heaviest allocations are Health Care 73.9%, Industrials 4.2%. Versus the prior quarter, allocation shifted toward Health Care (+7.7pp) and away from Industrials (-2.1pp), Other (-5.4pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 58% of names.

The largest new positions opened in Q2 2024 were RAPP ($68.39M), AXSM ($32.20M), ALMS ($28.56M).

Of the 2 positions fully exited versus the prior quarter, the largest were ALPN ($107.03M), AUTL ($42.21M), ALXO ($35.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • RAPP RAPPORT THERAPEUTICS INC · $68.39M
  • AXSM AXSOME THERAPEUTICS INC. · $32.20M
  • ALMS ALUMIS INC · $28.56M
  • URGN UROGEN PHARMA LTD · $27.69M
  • SRPT SAREPTA THERAPEUTICS INC · $19.75M
  • CGEM CULLINAN THERAPEUTICS INC · $19.62M
  • YMAB Y-MABS THERAPEUTICS INC · $17.52M
  • RNAM AVIDITY BIOSCIENCES INC · $17.36M

Fully Exited (vs previous quarter)

  • ALPN ALPINE IMMUNE SCIENCES INC · prev qtr: $107.03M
  • AUTL AUTOLUS THERAPEUTICS LTD · prev qtr: $42.21M
  • ALXO ALX ONCOLOGY HLDGS INC · prev qtr: $35.03M
  • AVTE AEROVATE THERAPEUTICS INC · prev qtr: $31.63M
  • MRNS MARINUS PHARMACEUTICALS INC · prev qtr: $29.38M
  • TRML TOURMALINE BIO INC · prev qtr: $28.62M
  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $23.51M
  • CABA CABALETTA BIO INC · prev qtr: $18.77M · history

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.9%
Other 21.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $373.49M 21.57%
21.57%
Hold
2 2.02M $91.63M 5.29%
Form 4 · 1 →
5.29%
Hold
3 1.52M $84.16M 4.86%
4.86%
Reduce
4 1.10M $83.06M 4.80%
4.80%
Add
5 2.79M $75.43M 4.36%
4.36%
Reduce
6 8.32M $72.43M 4.18%
4.18%
Add
7 2.94M $68.39M 3.95%
3.95%
New
8 1.35M $60.47M 3.49%
3.49%
Add
9 3.01M $54.15M 3.13%
3.13%
Hold
10 840.00K $49.70M 2.87%
2.87%
Add
11 1.86M $47.07M 2.72%
2.72%
Reduce
12 675.00K $45.23M 2.61%
2.61%
Add
13 2.30M $44.18M 2.55%
2.55%
Add
14 1.05M $43.98M 2.54%
2.54%
Add
15 400.00K $32.20M 1.86%
1.86%
New
16 975.00K $30.78M 1.78%
1.78%
Add
17 2.91M $29.73M 1.72%
1.72%
Hold
18 2.15M $28.56M 1.65%
1.65%
New
19 685.00K $28.33M 1.64%
1.64%
Reduce
20 2.13M $28.16M 1.63%
1.63%
Hold
21 801.96K $27.84M 1.61%
1.61%
Add
22 1.65M $27.69M 1.60%
1.60%
New
23 1.47M $27.57M 1.59%
1.59%
Reduce
24 2.52M $23.48M 1.36%
1.36%
Add
25 125.00K $19.75M 1.14%
1.14%
New
26 1.12M $19.62M 1.13%
1.13%
New
27 475.00K $19.50M 1.13%
1.13%
Reduce
28 1.18M $19.42M 1.12%
1.12%
Hold
29 1.45M $17.52M 1.01%
1.01%
New
30 425.00K $17.36M 1.00%
1.00%
New
31 3.57M $16.07M 0.93%
0.93%
Hold
32 1.61M $14.55M 0.84%
0.84%
Add
33 500.00K $13.59M 0.79%
0.79%
Reduce
34 625.00K $11.88M 0.69%
0.69%
Hold
35 515.00K $9.55M 0.55%
0.55%
Hold
36 1.00M $9.43M 0.55%
0.55%
Hold
37 265.83K $9.00M 0.52%
0.52%
Reduce
38 245.00K $8.60M 0.50%
0.50%
Reduce
39 1.25M $7.90M 0.46%
0.46%
New
40 593.04K $6.91M 0.40%
0.40%
Hold
41 75.00K $6.02M 0.35%
0.35%
Hold
42 427.16K $5.77M 0.33%
0.33%
Hold
43 2.60M $5.23M 0.30%
0.30%
Hold
44 107.34K $3.91M 0.23%
0.23%
Reduce
45 500.00K $3.79M 0.22%
0.22%
New
46 1.39M $2.75M 0.16%
0.16%
Hold
47 2.03M $2.03M 0.12%
0.12%
Reduce
48 350.00K $1.71M 0.10%
0.10%
Hold
49 496.75K $1.52M 0.09%
0.09%
Hold

FAQ

What did Cormorant Asset Management, LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Cormorant Asset Management, LP reported 49 equity positions worth $1.73B in aggregate; its largest disclosed positions were MLTX ($373.49M), CRBP ($91.63M), ACLX ($84.16M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $1.73B of long equity holdings across 49 positions as of 2024-Q2. Top-10 holdings account for 58.5% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →